bf/NASDAQ:MRNA_icon.jpeg

NASDAQ:MRNA

Moderna Inc.

  • Stock

USD

Last Close

63.94

25/09 14:39

Market Cap

45.01B

Beta: 1.70

Volume Today

1.01M

Avg: 3.57M

PE Ratio

−10.50

PFCF: −13.71

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
-86.50M
-
-538.59M
522.69%
-428.83M
20.38%
743.76M
273.44%
1.20B
60.67%
575.50M
51.84%
average payables
24.44M
-
25.97M
6.25%
19.15M
26.25%
12.72M
33.55%
160.18M
1,158.83%
394.50M
146.29%
503.50M
27.63%
average receivables
17.30M
-
23.62M
36.50%
23.44M
0.76%
713.41M
2,943.57%
2.35B
229.86%
2.34B
0.54%
1.14B
51.36%
book value per share
2.24
-
1.66
25.72%
18.87
1,034.40%
3.55
81.19%
6.72
89.41%
35.10
422.10%
48.54
38.28%
36.27
25.28%
capex per share
-0.09
-
-0.16
76.20%
-1.30
739.49%
-0.10
92.69%
-0.18
85.70%
-0.70
298.08%
-1.02
44.06%
-1.85
82.30%
capex to depreciation
-2.19
-
-2.84
29.68%
-4.25
49.60%
-1.02
76.09%
-2.16
112.18%
-1.22
43.28%
-1.15
6.10%
-1.14
0.95%
capex to operating cash flow
-0.50
-
0.18
135.47%
0.32
81.44%
0.07
78.49%
-0.03
148.40%
-0.02
37.34%
-0.08
285.13%
0.23
382.36%
capex to revenue
-0.33
-
-0.33
1.09%
-0.86
161.61%
-0.66
23.91%
-0.25
62.59%
-0.02
93.48%
-0.02
29.68%
-0.10
397.19%
cash per share
2.81
-
2.01
28.55%
18.76
832.83%
3.33
82.23%
12.09
262.91%
26.62
120.10%
25.13
5.58%
7.61
69.72%
days of inventory on hand
5.03K
-
2.14K
-
200.98
90.61%
63.96
68.18%
15.71
75.44%
days payables outstanding
-907.27
-
844.70
-
42.12
95.01%
32.82
22.08%
40.44
23.23%
days sales outstanding
64.53
-
34.35
46.77%
91.12
165.24%
123.83
35.91%
1.88K
1,414.66%
67.83
96.38%
26.24
61.31%
47.54
81.17%
debt to assets
0.03
-
0.08
207.63%
0.06
29.62%
0.13
119.36%
0.09
26.69%
0.04
59.75%
0.05
24.98%
0.07
49.81%
debt to equity
0.04
-
0.14
216.94%
0.07
47.97%
0.17
131.45%
0.26
55.22%
0.06
75.50%
0.06
3.10%
0.09
47.35%
dividend yield
0.00
-
0.00
584.95%
earnings yield
-0.03
-
-0.04
18.36%
-0.31
748.84%
-0.08
74.44%
-0.02
76.36%
0.12
735.16%
0.12
0.89%
-0.12
205.02%
enterprise value
6.96B
-
6.87B
1.17%
613.74M
91.07%
6.37B
938.04%
37.39B
486.84%
96.42B
157.91%
68.77B
28.68%
36.30B
47.21%
enterprise value over ebitda
-33.34
-
-27.63
17.12%
-1.49
94.62%
-11.67
686.09%
-48.99
319.64%
7.25
114.80%
7.04
2.92%
-8.56
221.64%
ev to operating cash flow
104.24
-
-20.74
119.90%
-1.85
91.06%
-13.88
648.31%
18.44
232.88%
7.08
61.62%
13.81
95.01%
-11.64
184.33%
ev to sales
68.51
-
38.84
43.30%
5.01
87.10%
132.63
2,547.44%
136.20
2.70%
5.44
96.01%
3.57
34.34%
5.30
48.49%
free cash flow per share
0.09
-
-1.04
1,260.72%
-5.38
419.12%
-1.48
72.47%
5.14
447.05%
33.09
543.42%
11.63
64.86%
-10.01
186.12%
free cash flow yield
0.00
-
-0.06
1,260.72%
-0.35
532.33%
-0.08
78.51%
0.05
164.98%
0.13
164.66%
0.06
50.32%
-0.10
255.54%
graham net net
1.32
-
0.82
37.67%
12.65
1,437.46%
0.75
94.06%
2.40
219.31%
8.43
251.45%
11.88
40.99%
-2.34
119.72%
graham number
5.38
-
5.05
6.24%
44.87
789.12%
11.14
75.18%
17.22
54.65%
154.63
797.89%
152.24
1.55%
100.35
34.09%
income quality
-0.31
-
1.30
519.66%
0.86
33.61%
0.89
3.83%
-2.71
403.87%
1.12
141.14%
0.60
46.63%
0.66
11.04%
intangibles to total assets
0
-
0
0
0
0
-0.06
Infinity%
0
100%
0
interest coverage
-82.53
-
-77.19
6.47%
738.67
1,056.89%
324.83
56.03%
interest debt per share
0.10
-
0.24
135.41%
1.39
490.23%
0.62
55.02%
1.80
188.75%
2.32
28.57%
3.12
34.59%
3.35
7.51%
inventory turnover
0.07
-
0.17
-
1.82
965.14%
5.71
214.25%
23.23
307.09%
invested capital
0.04
-
0.14
216.94%
0.07
47.97%
0.17
131.45%
0.26
55.22%
0.06
75.50%
0.06
3.10%
0.09
47.35%
market cap
6.99B
-
6.99B
0%
1.24B
82.29%
6.47B
422.71%
39.80B
514.78%
102.35B
157.15%
70.77B
30.86%
37.99B
46.32%
net current asset value
511.84M
-
324.03M
36.69%
1.13B
249.07%
848.38M
25.00%
1.52B
79.46%
7.05B
362.79%
6.70B
4.97%
5.75B
14.08%
net debt to ebitda
0.18
-
0.48
165.93%
1.51
215.70%
0.19
87.46%
3.17
1,569.43%
-0.45
114.09%
-0.21
53.99%
0.40
294.11%
net income per share
-0.58
-
-0.68
18.36%
-4.74
596.87%
-1.55
67.26%
-1.96
26.26%
30.28
1,644.16%
21.22
29.90%
-12.34
158.14%
operating cash flow per share
0.18
-
-0.88
596.72%
-4.08
362.68%
-1.39
66.01%
5.32
483.68%
33.80
535.26%
12.64
62.59%
-8.16
164.56%
payables turnover
-0.40
-
0.43
-
8.67
1,905.43%
11.12
28.34%
9.03
18.85%
receivables turnover
5.66
-
10.63
87.85%
4.01
62.30%
2.95
26.42%
0.19
93.40%
5.38
2,665.18%
13.91
158.47%
7.68
44.80%
research and ddevelopement to revenue
2.71
-
2.32
14.28%
3.71
59.81%
10.33
178.76%
4.99
51.68%
0.11
97.75%
0.17
52.38%
0.71
313.62%
return on tangible assets
-0.15
-
-0.24
54.67%
-0.20
16.91%
-0.32
64.94%
-0.10
68.51%
0.47
557.94%
0.32
30.65%
-0.26
179.11%
revenue per share
0.27
-
0.47
74.30%
1.51
220.89%
0.15
90.39%
0.72
396.44%
44.01
6,008.70%
48.89
11.09%
17.93
63.33%
roe
-0.26
-
-0.41
59.36%
-0.25
38.57%
-0.44
74.03%
-0.29
33.34%
0.86
395.76%
0.44
49.31%
-0.34
177.81%
roic
-0.25
-
-0.37
46.44%
-0.25
33.16%
-0.36
46.54%
-0.22
38.54%
0.76
443.92%
0.39
49.53%
-0.31
180.36%
sales general and administrative to revenue
0.57
-
0.37
35.36%
0.77
110.36%
2.28
196.63%
shareholders equity per share
2.24
-
1.66
25.72%
18.87
1,034.40%
3.55
81.19%
6.72
89.41%
35.10
422.10%
48.54
38.28%
36.27
25.28%
stock based compensation to revenue
0.39
-
0.23
41.61%
0.59
161.70%
1.69
185.12%
0.34
79.93%
0.01
97.64%
0.01
46.54%
0.04
279.62%
tangible asset value
841.85M
-
625.30M
25.72%
1.53B
144.72%
1.17B
23.23%
2.56B
118.02%
15.64B
510.77%
19.12B
22.24%
13.85B
27.55%
tangible book value per share
2.24
-
1.66
25.72%
18.87
1,034.40%
3.55
81.19%
6.72
89.41%
35.10
422.10%
48.54
38.28%
36.27
25.28%
working capital
924.35M
-
591.76M
35.98%
1.34B
126.48%
1.12B
16.44%
1.91B
70.47%
8.44B
342.20%
8.51B
0.78%
7.31B
14.08%

All numbers in USD (except ratios and percentages)